the aid library

LIST OPTIONS

Filter

6581

Download (326)

View PDF (412)

Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : Système Xpert MTB/RIF

Organisation mondiale de la Santé (2011) C_WHO

Download (304)

View PDF (480)

Programmatic management of latent TB infection: Global perspective and updates

Global TB Programme: H. Getahun, MD, MPH, PhD. World Health Organization (2017) C_WHO

End TB. Accessed in November 2017.

External Link

Vitamin D Deficiency and Tuberculosis Progression

N. Talat, S. Perry, J. Personnet, et al. (2010) C_CDC

Emerging Infectious Diseases Vol. 16, No. 5, May 2010

Download (481)

View PDF (1210)

Hinweise zur Malaria-Diagnostik und zur Interpretation von Malaria-Befunden bei einer Person, bei der ein Verdacht auf eine Infektion mit einem Erreger VHF besteht

Robert-Koch-Institut RKI (2018) C1

Erreger virales hemorraghisches Fieber (hier: Ebola-, Krim-Kongo-, Lassa-, Marburgvirus) und sich noch nicht in einem STAKOB Behandlungszentrum befindet (Stand 30.5.2018) Wenn der Verdacht auf eine reiseassoziierte Infektion mit einem Erreger eines viral-hämorrhagischen Fiebers (VHF) bei einem fi... more

Download (158)

View PDF (193)

Руководство по лечению туберкулеза у детей, для национальных программ борьбы с туберкулезом

Dr. Стивена Грэхема, Dr. Малгосии Грземска, Dr. Сюзанны Хилл et al. WHO (2014) C_WHO

Как и руководство 2006 года, настоящий документ предназначен для специалистов, занимающихся разработкой государственных программ по борьбе с туберкулезом, педиатр... more

Download (182)

View PDF (215)

Antiretroviral Treatment in the Spotlight: A Public Health Analysis in Latin America and the Caribbean 2013

M. A. Jiménez; S. Cabrera; J. J. Fiol; et al. Pan American Health Organization; World Health Organization (Americas) (2013) C_WHO

Washington, DC, 2013

Download (137)

View PDF (177)

occupied Palestinian territory COVID-19 Response Plan (27 March 2020)

UN Office for the Coordination of Humanitarian Affairs (OCHA) (2020) C_WHO

The primary focus of the plan continues to be prevention, preparedness and treatment of the the Novel Coronavirus (COVID-19) outbreak. Central to the plan are the following overall objectives: To prevent further transmission of COVID-19 in the oPt; To provide adequate care for patients aff... more

Download (212)

View PDF (193)

COVAX: Structure and Principles

World Health Organization WHO (2022) C_WHO

This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of... more

External Link

Introduction: Leptospirosis Fact Sheet

World Health Organization WHO (2009) C_WHO

Leptospirosis is an infectious disease caused by pathogenic organisms belonging to the genus Leptospira, that are transmitted directly or indirectly from animals to humans. Leptospirosis is a major direct zoonosis. Humanto-human transmission occurs only very rarely.

Download (285)

View PDF (236)

Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases

World Health Organization WHO (2022) C_WHO

Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ... more

Download (258)

View PDF (238)

Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2021 global survey

World Health Organisation (WHO) (2023) C_WHO

To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ... more

Download (108)

View PDF (94)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (271)

View PDF (225)

Phénobarbital: mort au combat

N. B Ilangaratne; N. N. Mannakkara; G. S. Bel; et al. Organisation mondiale de la Santé (2012) C_WHO

Bulletin de l'Organisation mondiale de la Santé 2012;90:871-871A. doi: 10.2471/BLT.12.113183 Bulletin de l'Organisation mondiale de la Santé Numéros précédents Volume 90: 2012 Volume 90, Numéro 12, décembre 2012, 869-944

Download (412)

View PDF (642)

Journey of ART Programme in India. Story of a decade

National AIDSControl (NACO), Government of India; Ministry of Health and Family Welfare, et al. (2015) C1

Celebrating ten years of success 2004-2014

Download (1045)

View PDF (3576)

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended

World Health Organization WHO (2011) C_WHO

The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o... more

Download (15589)

View PDF (1198)

Neuraxial Blockade and Anticoagulation - Handout

International federation of nurse anesthetics (2014)

Handout presentations in PDF for illustrating lectures Accessed May 2014

Download (200)

View PDF (225)

Maintaining and prioritizing HIV prevention services in the time of COVID-19

UNAIDS; GPC (2020) CC

In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i... more

Download (198)

View PDF (268)

Tuberculosis and COVID-19

BC Centre for Disease Control (2021) CC

Download (270)

View PDF (324)

Autism and asperger's: for parents, carers and anyone working with young people

Royal College of Psychiatrists (2019) C2

This webpage gives details about Autism and Autism Spectrum Disorders, as well as offering practical advice about how to get help. Accessed: 29.03.2019

Download (283)

View PDF (218)

Transforming the medical PPE ecosystem: Joint action can protect healthcare workers with effective and high-quality personal protective equipment

Global Fund (2021) CC

Access to medical personal protective equipment (PPE) is essential for routine healthcare delivery, and a critical tool for containing outbreaks, as well as preventing and responding to pandemics. It is one of our most effective tools against COVID-19, and an undervalued tool more generally in infec... more

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa recommended

Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended